insights_auto
Outlook: 56.0% bullish·8.0% bearish
Go to analysischevron_right
REGN:NASDAQ
Regeneron Pharmaceuticals Inc
$955.47
arrow_upward
+0.45%(+4.28) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
$952.47
High
$961.94
Low
$942.00
Mkt. cap
98.84B
Avg. vol.
870.77K
Volume
1.17M
Dividend
0.39%
Quarterly dividend
$0.94
Ex-dividend date
Nov 20, 2026
P/E ratio
21.10
52-wk high
$991.73
52-wk low
$591.52
EPS
$45.28
Beta
0.10
Shares outstanding
101.63M
No. of employees
15K
Open
$952.47
High
$961.94
Low
$942.00
Mkt. cap
98.84B
Avg. vol.
870.77K
Volume
1.17M
Dividend
0.39%
Quarterly dividend
$0.94
Ex-dividend date
Nov 20, 2026
P/E ratio
21.10
52-wk high
$991.73
52-wk low
$591.52
EPS
$45.28
Beta
0.10
Shares outstanding
101.63M
No. of employees
15K
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Regeneron Has $16 Billion in Net Cash and Trades Near 20 Times Earnings. Is It the Cheapest Big Biotech?
Benzinga
·
2 days ago
Regeneron Drug Lowers Standing Heart Rate And Improves Symptoms In Heart Disease Study
TradingView
·
3 days ago
REGN Soars 27.4% in a Month: Buy, Sell or Hold the Stock?
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorHealth Care
IndustryBiotechnology
Websiteregeneron.com